ASCO 2021: Pembrolizumab as adjuvant therapy for kidney cancer
Adjuvant therapy is medication that is given in addition to [...]
Adjuvant pembrolizumab extends disease-free survival in kidney cancer patients
Interim results from a phase 3 clinical trial called KEYNOTE-564 [...]
IKCS 2020: Treatment selection in kidney cancer
During this interview, Dr Rana McKay from the University of [...]
Stereotactic radiation for the treatment of kidney cancer
This paper reviews the use of stereotactic body radiotherapy (SBRT) [...]
ESMO 2019: Results from SORCE clinical trial with adjuvant sorafenib
Results from the SORCE clinical trial to assess sorfenib as [...]
ASCO 2019: Effectiveness of pazopanib after kidney cancer metastasectomy
In this phase III study, presented at the American Society [...]
A review of adjuvant therapy options for kidney cancer
In this paper, published in Current Treatment Options in Oncology [...]
Lymph node dissection identifies patients at high risk of kidney cancer spread
A recent study published in the journal Science Direct suggests that [...]
ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma
The following presentations were given at the European Association of [...]
MD Anderson Cancer Center 13th Update on the Management of Genitourinary Malignancies Conference
The MD Anderson Cancer Center (MDACC) 13th Update on the [...]
